Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)

INTRODUCTION: Although there are studies about sepsis treatment in different age groups, data on immunoglobulin-M (IgM)-enriched intravenous immunoglobulin use in pediatric intensive care units (PICUs) are limited. The aim of this study was to evaluate the clinical features and prognoses of children...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Hum Vaccin Immunother
Päätekijät: Abdullayev, Emin, Kilic, Omer, Bozan, Gurkan, Kiral, Eylem, Iseri Nepesov, Merve, Dinleyici, Ener Cagri
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2020
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7482735/
https://ncbi.nlm.nih.gov/pubmed/32040371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1711298
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia